Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,956 total articles
Palantir is trading like a high-growth AI winner: exceptional revenue momentum and cash generation but an elevated multiple. This trade idea buys into continued commercial adoption and defense tailwinds while protecting capital with a clear stop and a mid-term target that defends the premium.
Magnite has been punished on guidance noise and sector rotation, but the balance sheet, FCF generation, and valuations (PE ~12.8, EV/EBITDA ~11.4) leave limited downside and attractive upside if ad demand normalizes. This is a tactical, position-sized long with defined risk.
Alumis' oral TYK2 candidate envudeucitinib just cleared a major Phase 3 hurdle and the company has bolstered its balance sheet with a $300M upsized offering. At a $3.0B market cap and stretched valuation metrics, the stock is priced for perfection, but the combination of clinical success, improved funding and a meaningful short base creates a tacti…
Rubrik recently delivered a clean quarter — $377.7M revenue, 50% subscription revenue growth, and subscription ARR of $1.46B — yet the stock has been punished into the mid-$40s. Fundamentals argue for recovery; technicals and sentiment keep near-term pressure. This trade idea buys the disconnect with a disciplined stop and a sensible target tied to…
A.O. Smith (AOS) deserves a rating upgrade to a cautiously optimistic stance. The company's free cash flow generation ($546M), low debt-to-equity (0.08) and attractive dividend yield (~2.1%) create a defensive base. Technicals show the stock has pulled back toward technical support and the sector backdrop for tankless and energy-efficient water hea…
Magnite is trading below its moving averages on weak momentum, but fundamentals show healthy cash flow generation, a reasonable P/E near 12.8 and double-digit CTV growth. This trade idea is a mid-term long that attempts to capture a renewed re-rating if CTV continues to outpace legacy declines and guidance stabilizes.
Nebius' $27 billion hyperscaler deal rattled sentiment today, but NVIDIA's scale, recent disclosed customer wins and enormous free cash flow make the current pullback a measured opportunity. This trade idea offers an actionable long position with a clear entry, stop and target, plus a balanced risk framework and catalysts to watch.
Salesforce (CRM) is trading like growth is permanently dead. We see a high-probability rebound over the next 45 trading days if the company delivers steady recurring revenue and margin stabilization. This trade lays out a specific entry, stop and target with clear time framing and risk controls.
Soitec is positioned to benefit from accelerating demand for photonics-enabled interconnects, LiDAR and sensing, and high-efficiency power devices. We recommend a long trade with an entry at $32.50, a stop at $26.00, and a target of $52.00 over a long-term horizon (180 trading days). The setup offers a favorable risk-reward while leaving room to re…
Monster Beverage (MNST) is showing near-term technical strain, but its cash flow, margins and distribution muscle argue for a long-term trade. We outline an actionable plan with entry, stop and target and explain the catalysts and risks that could play out over the next 180 trading days.
IVOL combines TIPS exposure with long options on the interest-rate swap curve. With the ETF trading near the low end of its range, elevated short interest and technicals suggesting a base, this trade buys optionality for a mid-term rebound driven by renewed Treasury volatility or inflation surprises. Entry, stop and target provided with clear horiz…
Booking Holdings (BKNG) is trading at roughly 15x free cash flow and an EV/EBITDA in the mid-teens despite generating roughly $9.1B of FCF and owning category-leading brands. For investors who believe the company can continue compounding revenue and FCF at high single digits to mid-teens, the current price offers an attractive entry. This trade ide…
Surge Energy is a high-beta oil & gas producer that should see disproportionate free cash flow upside as crude continues its recovery. This trade outlines a tactical long with tight risk control and a mid-term horizon to capture operational and price catalysts.
Arm's debut of a physical AI CPU with marquee customers has re-rated the stock. With $165.3B market cap, strong technical momentum, and a clear path to higher royalties and chip sales, I put forward a mid-term bullish swing trade (45 trading days) with an entry at $150, stop at $135, and an initial target of $185. The thesis balances execution risk…
Astronics (ATRO) has patched several near-term execution issues and added targeted revenue from bolt-on deals. With a $2.48B market cap, improving free cash flow and a growing aircraft lighting and electrical-systems market, the risk/reward looks favorable for a mid-term trade. I recommend a controlled long position with a stop below recent support…
American Superconductor (AMSC) is a small-cap power-electronics and grid-resilience play that has started to re-rate after a string of operational wins and a strategic acquisition. The stock is trading at $32.99 with improving technicals, 2025 revenue momentum, and a strengthened product portfolio after the Comtrafo deal. This trade idea outlines a…
Black Diamond Therapeutics (BDTX) is a small-cap oncology developer with a focused bet on BDTX-1535, a brain-penetrant EGFR MasterKey inhibitor. The market has largely shrugged at recent clinical and licensing news; valuation metrics and a modest float create a tradeable, asymmetric risk-reward. I outline a long trade with clear entry, stop and tar…
Cal‑Maine (CALM) is an underappreciated cash machine trading at single‑digit multiples. Ahead of earnings, the stock offers a compelling mid‑term long trade: buy at current levels, stop tight under the winter low, target a re-rating toward a conservative multiple as recent M&A and prepared‑foods expansion start to show through.
Microsoft (MSFT) is trading near its 52-week low after a heavy sell-off tied to AI capex and margin worries. With a $2.77T market cap, strong free cash flow ($77.4B trailing), low leverage (debt/equity ~0.10) and an oversold technical picture (RSI ~28), the pullback looks like a high-probability long setup. This trade pairs a tactical entry at $376…
Citizens Financial Services (CZFS) trades at roughly $60.66 with a P/E near 8 and P/B below 1, yet reported meaningful net income gains in 2025 driven by higher net interest income and lower credit loss provisions. If interest rates begin a sustained decline, CZFS's combination of improving fundamentals, a 3.26% yield and a compact float makes it a…
Duke Energy's regulated footprint across the Carolinas and Florida, growing capital plan, and reliable dividend create a favorable risk/reward as AI data center demand lifts Sunbelt power consumption. Valuation is reasonable for a regulated utility, balance sheet leverage is the primary watch item, and near-term catalysts could drive a re-rating to…
First Watch (FWRG) finished fiscal 2025 with heavy unit growth, positive same-restaurant sales and traffic, and a system of 633 restaurants. The stock trades at roughly $11.45 with a market cap near $700M, EV/EBITDA ~9.3 and a P/E north of 36. For investors willing to look out 6+ months, this combination of growth and reasonable enterprise multiple…
Aeluma is shifting from lab-scale IP to wafer-scale photonic manufacturing. Recent capital raises, equipment purchases, and government contract wins materially de-risk the path to commercialization. The risk-reward is asymmetric for disciplined traders: expensive on sales today but potentially re-rated if production-ready demos and incremental reve…
Crescent Energy (CRGY) looks like a mid-cap shale operator the market has underpriced. With a roughly $4.29B market cap, an accretive Vital Energy tie-up, attractive EV/EBITDA and P/B multiples, and a 3%+ yield, Crescent offers a favorable risk/reward for a long trade over the next 180 trading days. The plan: buy at $13.08, stop at $11.20, target $…
Booking Holdings has been punished on fears of AI disruption and a busy news cycle around a 25-for-1 stock split. The underlying business remains cash-generative, with trailing free cash flow near $9.1B and a market cap of roughly $136B. Technicals show an orderly dip and momentum turning constructive; valuation metrics and a healthy FCF yield argu…
